Patient and retina specialists' preferences in neovascular age-related macular degeneration treatment. A discrete choice experiment.

ABSTRACT:

Introduction and objective

Neovascular age-related macular degeneration (nAMD) leads to severe and permanent visual impairment, significantly impacting patients' quality of life and functional independence. Although treatment with anti- vascular endothelial growth factor (VEGF) prevents and, in some cases, reverses visual damage, the need for frequent monitoring visits and intravitreal injections represents a significant burden on patients, caregivers and retina specialists.

Objective

To elicit preferences for nAMD treatment characteristics from the perspectives of patients and retina specialists.

Method

A discrete choice experiment was conducted. Participants (patients > 50 years with nAMD receiving anti-VEGF drugs for at least 2 years and without previous experience

SUBMITTER: Gallego-Pinazo R 

PROVIDER: S-EPMC8719669 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature